• Programmatic & finance policies

in page functions
  • Programme policies are developed to set coherent principles for all GAVI-eligible countries and to guide specific decisions conducive to GAVI’s mission. These policies are approved by the GAVI Board and reviewed on a regular basis.

  • 24 September 2012

    Access to Information Policy

    The Access of Information Policy sets out the categories of documents that shall be made publicly available to external audiences through the GAVI website and other appropriate means of communication, to operate in a transparent and accountable manner.

    28 February 2011

    Co-financing policy

    Co-financing means that countries contribute to the cost of GAVI-supported vaccines by procuring some of the required vaccine doses with non-GAVI funds. The level of required co-financing takes into account a country’s ability to pay and is dependent on its income (GNI) per capita.

    07 March 2011

    Country eligibility policy

    GAVI aims to focus its funding support on the world’s poorest countries most in need of support. Eligibility is therefore determined by national income with all countries with a Gross National Income (GNI) per capita below or equal to US$1,550 (according to World Bank data for the latest available year) qualifying for support. Under the revised eligibility policy, there are currently 56 “GAVI-eligible” countries.

    05 March 2013

    GAVI policy on fragility and immunisation

    In December 2012, the GAVI Alliance Board approved a policy that allows tailored approaches to be applied to fragile states and time-limited responses to be extended to countries in short-term emergency situations, with the aim to improve or protect immunisation systems in GAVI-supported countries. The policy enables GAVI to work with our partners to strengthen our focus on countries that require more intensive support and attention.

    07 March 2011

    Gender policy

    The GAVI Alliance gender policy recognises equal access to immunisation as a key factor in ensuring expanded, equitable vaccine coverage and strengthened health services.

    07 March 2011

    Graduation policy

    GAVI aims to focus its support on the poorest countries. Therefore, countries whose Gross National Income (GNI) per capita crosses the GAVI eligibility threshold (currently US$1,550) enter a graduation process and are no longer eligible to apply for new GAVI funding.

    07 March 2011

    Pilot Prioritisation Mechanism

    In June 2010, the GAVI Board approved a mechanism which allows the ranking of technically sound proposals from GAVI-eligible countries and the subsequent prioritisation of funding choices.

    18 March 2013

    Self-procurement policy

    This policy outlines how countries opting for self-procurement should only use GAVI funds to purchase vaccines and related injection safety supplies (auto-disable syringes, syringe and needle disposal boxes) that meet international expectations of assured quality.

    01 April 2011

    How tap works

    Transparency and accountability policy

    On 1 January 2009, GAVI enacted a new Transparency & Accountability Policy (TAP) that aims at managing fiduciary risk in GAVI-supported countries.

    07 March 2011

    Vaccine donation policy

    Donations of vaccines by industry to international organisations or to governments can bring benefits if properly managed, but also carry certain risks. GAVI only accepts vaccines donations under exceptional circumstances and requires both the manufacturer and recipient country to comply with a number of conditions.

    19 June 2012

    Vaccine introduction grants and operational support for campaigns policy

    GAVI provides a cash grant to countries ahead of each new vaccine introduction to facilitate the timely and effective implementation of critical preparation activities. GAVI also provides cash support to cover a share of the delivery cost of vaccination campaigns.

  • 296 million

    Since its launch in 2000, GAVI support has resulted in the immunisation of 296 million children with the hepatitis B vaccine.

    WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, November 2010

    More facts...

close icon

modal window here